Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POINT: Corticosteroids for Uveitic Macular Edema
NCT02374060Phase 3Completed
- Sponsor
- Johns Hopkins Center for Clinical Trials and Evidence Synthesis
- Start
- Jun 2015
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of triamcinolone, dexamethasone in uveitic macular edema (UME), sponsored by Johns Hopkins Center for Clinical Trials and Evidence Synthesis. Started Jun 2015; status: completed.
02
Drugs
triamcinolonedexamethasone
03
Conditions
uveitic macular edema (UME)
Beyond the preview
Go deeper on NCT02374060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374060.